CG Oncology, Inc.
Ownership
Ownership Structure
Who owns CG Oncology, Inc. (CGON)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.0% of the shares are freely tradable; institutional investors hold 109.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RTW INVESTMENTS, LLC | 9.61 | 8,514,590 | +21.9 | 06/30/2026 |
| T. Rowe Price Investment Management,Inc. | 7.46 | 6,616,899 | -1.5 | 06/30/2026 |
| Decheng Capital LLC | 7.19 | 6,371,669 | +0.0 | 06/30/2026 |
| BlackRock Inc | 7.06 | 6,256,288 | +23.5 | 06/30/2026 |
| Wellington Management Company LLP | 6.01 | 5,324,751 | -0.9 | 06/30/2026 |
| FMR Inc | 4.69 | 4,161,493 | +10.5 | 06/30/2026 |
| T. Rowe Price Associates, Inc. | 4.29 | 3,805,010 | +4.2 | 06/30/2026 |
| TCG Crossover Management, LLC | 4.14 | 3,670,206 | +0.0 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 3.91 | 3,465,197 | +12.0 | 06/30/2026 |
| State Street Corp | 3.88 | 3,437,590 | +29.9 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Post Leonard E | Director | Sell | 500 | 62.48 | 31,240 |
| Oct 15, 2026 | Post Leonard E | Director | Other | 1,000 | 0.60 | 600 |
| Sep 15, 2026 | Post Leonard E | Director | Sell | 1,000 | 72.98 | 72,980 |
| Sep 15, 2026 | Post Leonard E | Director | Other | 1,000 | 0.60 | 600 |
| Aug 14, 2026 | Post Leonard E | Director | Sell | 1,000 | 74.54 | 74,540 |
| Aug 14, 2026 | Post Leonard E | Director | Other | 1,000 | 0.60 | 600 |
| Jul 15, 2026 | Post Leonard E | Director | Sell | 1,000 | 71.17 | 71,170 |
| Jul 15, 2026 | Post Leonard E | Director | Other | 1,000 | 0.60 | 600 |
| Jul 10, 2026 | Mulay James | Director | Sell | 24,165 | 75.16 | 1,816,241 |
| Jul 10, 2026 | Mulay James | Director | Other | 24,165 | 26.63 | 643,514 |
| Apr 17, 2026 | James Mulay | Director | Sell | 15,600 | 73.01 | 1,138,956 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.